Regulation of in vitro Aβ1-40 aggregation mediated by small molecules

Hye Yun Kim, Youngsoo Kim, Gyoonhee Han, Dong Jin Kim

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)


It is well known that the transient and prolonged misfolding nature of amyloid-β (Aβ) makes it difficult to perform proper in vitro studies and obtain consistent results. From monomers to fibrils, the aggregated forms of Aβ are significant hallmarks in the Alzheimer's disease (AD) cascade and become the valuable targets for early diagnosis and therapy for AD. Thus, development of optimized in vitro fibrillogenic conditions to induce the desired Aβ states is essential to AD research. In this study, fifteen organic amino acid compounds (glycine, taurine, tramiprosate, and their derivatives) were employed to induce different fibrillogenic conditions for Aβ. The fibrillogenic patterns of Aβ peptides in these compounds were analyzed by thioflavin T assay and SDS-PAGE with photoinduced cross-linking of unmodified proteins protocols, then were analyzed and compared to those obtained via transmission electron microscopy and neuronal cell viability assays. Our study suggests various compounds capable of inducing different levels of in vitro Aβ1-40 fibrillogenesis, potentially useful tools in the study of Aβ for AD.

Original languageEnglish
Pages (from-to)73-85
Number of pages13
JournalJournal of Alzheimer's Disease
Issue number1
Publication statusPublished - 2010

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health


Dive into the research topics of 'Regulation of in vitro Aβ1-40 aggregation mediated by small molecules'. Together they form a unique fingerprint.

Cite this